| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sodium-Calcium Exchanger | 19 | 2015 | 69 | 3.600 |
Why?
|
| Histone Deacetylase Inhibitors | 9 | 2018 | 116 | 2.780 |
Why?
|
| Histone Deacetylases | 9 | 2018 | 99 | 2.560 |
Why?
|
| Myocytes, Cardiac | 23 | 2021 | 442 | 2.540 |
Why?
|
| Myocardial Reperfusion Injury | 4 | 2020 | 84 | 2.150 |
Why?
|
| Heart | 19 | 2020 | 850 | 2.040 |
Why?
|
| Histone Deacetylase 1 | 6 | 2018 | 32 | 1.950 |
Why?
|
| Myocardial Infarction | 6 | 2020 | 807 | 1.850 |
Why?
|
| Myocardium | 20 | 2021 | 1204 | 1.420 |
Why?
|
| Cardiomegaly | 14 | 2015 | 213 | 1.370 |
Why?
|
| Gene Expression Regulation | 11 | 2015 | 1293 | 1.210 |
Why?
|
| Bacteriorhodopsins | 11 | 2000 | 47 | 1.070 |
Why?
|
| Hydroxamic Acids | 5 | 2015 | 84 | 1.070 |
Why?
|
| Reperfusion Injury | 3 | 2020 | 320 | 0.960 |
Why?
|
| Cats | 21 | 2015 | 292 | 0.920 |
Why?
|
| Up-Regulation | 8 | 2009 | 682 | 0.890 |
Why?
|
| Animals | 52 | 2020 | 20881 | 0.820 |
Why?
|
| Organoids | 5 | 2022 | 42 | 0.750 |
Why?
|
| Calcium-Transporting ATPases | 7 | 1996 | 40 | 0.710 |
Why?
|
| Mice | 24 | 2020 | 8474 | 0.690 |
Why?
|
| Promoter Regions, Genetic | 11 | 2015 | 615 | 0.660 |
Why?
|
| Protons | 9 | 2000 | 57 | 0.650 |
Why?
|
| Coronary Vessels | 2 | 2018 | 313 | 0.640 |
Why?
|
| CCN Intercellular Signaling Proteins | 1 | 2018 | 3 | 0.620 |
Why?
|
| Energy Metabolism | 1 | 2020 | 222 | 0.620 |
Why?
|
| Fibroblasts | 4 | 2020 | 902 | 0.610 |
Why?
|
| Flavobacterium | 5 | 1996 | 6 | 0.600 |
Why?
|
| Microtubules | 10 | 2010 | 104 | 0.540 |
Why?
|
| Arginine | 6 | 2000 | 102 | 0.540 |
Why?
|
| Wound Healing | 1 | 2018 | 260 | 0.540 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 411 | 0.520 |
Why?
|
| Isolated Heart Preparation | 1 | 2015 | 8 | 0.520 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 101 | 0.510 |
Why?
|
| Ventricular Function, Left | 4 | 2020 | 481 | 0.510 |
Why?
|
| Neovascularization, Physiologic | 4 | 2020 | 164 | 0.480 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 145 | 0.470 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 160 | 0.470 |
Why?
|
| Rats | 12 | 2018 | 5300 | 0.470 |
Why?
|
| Pyridines | 2 | 2014 | 261 | 0.460 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2011 | 93 | 0.450 |
Why?
|
| Receptors, Adrenergic, beta | 3 | 2013 | 153 | 0.450 |
Why?
|
| Benzamides | 1 | 2014 | 156 | 0.430 |
Why?
|
| Mitochondria | 1 | 2017 | 643 | 0.430 |
Why?
|
| Lysine | 4 | 2014 | 96 | 0.420 |
Why?
|
| Inflammation | 1 | 2018 | 1030 | 0.400 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2009 | 134 | 0.390 |
Why?
|
| Light | 7 | 2000 | 152 | 0.390 |
Why?
|
| Carrier Proteins | 5 | 1997 | 597 | 0.380 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2018 | 328 | 0.380 |
Why?
|
| Base Sequence | 12 | 2006 | 1015 | 0.370 |
Why?
|
| MicroRNAs | 1 | 2015 | 447 | 0.360 |
Why?
|
| Monosaccharide Transport Proteins | 10 | 1994 | 54 | 0.360 |
Why?
|
| Tubulin | 7 | 2008 | 60 | 0.360 |
Why?
|
| Kinetics | 19 | 2008 | 1047 | 0.350 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2009 | 26 | 0.350 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 61 | 0.350 |
Why?
|
| Retinal Diseases | 1 | 2010 | 40 | 0.340 |
Why?
|
| Thiourea | 1 | 2009 | 16 | 0.340 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2009 | 250 | 0.330 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 940 | 0.320 |
Why?
|
| Nanowires | 3 | 2017 | 11 | 0.310 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2021 | 86 | 0.310 |
Why?
|
| Symporters | 8 | 1991 | 27 | 0.310 |
Why?
|
| Retina | 1 | 2010 | 252 | 0.300 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2012 | 43 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2018 | 2083 | 0.300 |
Why?
|
| Escherichia coli Proteins | 8 | 1991 | 65 | 0.300 |
Why?
|
| Mutagenesis, Site-Directed | 10 | 2005 | 204 | 0.290 |
Why?
|
| Membrane Transport Proteins | 8 | 1991 | 81 | 0.290 |
Why?
|
| Acetylation | 3 | 2020 | 94 | 0.290 |
Why?
|
| Molecular Sequence Data | 13 | 2006 | 1447 | 0.290 |
Why?
|
| Genes, Reporter | 6 | 2010 | 191 | 0.280 |
Why?
|
| Mutation | 14 | 2015 | 1213 | 0.270 |
Why?
|
| Reactive Oxygen Species | 2 | 2020 | 499 | 0.270 |
Why?
|
| Signal Transduction | 4 | 2016 | 2689 | 0.270 |
Why?
|
| Calcium | 8 | 2013 | 929 | 0.270 |
Why?
|
| Escherichia coli | 10 | 1994 | 368 | 0.260 |
Why?
|
| Disease Models, Animal | 6 | 2018 | 2550 | 0.260 |
Why?
|
| Heart Diseases | 2 | 2022 | 276 | 0.260 |
Why?
|
| Microtubule-Associated Proteins | 5 | 2010 | 114 | 0.250 |
Why?
|
| Ventricular Remodeling | 3 | 2018 | 318 | 0.250 |
Why?
|
| Endothelial Cells | 2 | 2018 | 384 | 0.240 |
Why?
|
| Myocardial Contraction | 6 | 2014 | 383 | 0.240 |
Why?
|
| Sodium | 5 | 1997 | 161 | 0.240 |
Why?
|
| Homeobox Protein Nkx-2.5 | 3 | 2015 | 27 | 0.230 |
Why?
|
| Cells, Cultured | 9 | 2021 | 2673 | 0.230 |
Why?
|
| Hydrogen-Ion Concentration | 11 | 2000 | 618 | 0.230 |
Why?
|
| Transcription Factors | 3 | 2009 | 753 | 0.220 |
Why?
|
| Male | 12 | 2018 | 37321 | 0.220 |
Why?
|
| Mice, Transgenic | 9 | 2012 | 1033 | 0.220 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 562 | 0.210 |
Why?
|
| Extracellular Matrix | 5 | 2017 | 493 | 0.210 |
Why?
|
| Phosphorylation | 9 | 2011 | 1200 | 0.210 |
Why?
|
| Silicon | 3 | 2017 | 20 | 0.210 |
Why?
|
| Humans | 20 | 2022 | 68618 | 0.210 |
Why?
|
| Transcriptional Activation | 2 | 2015 | 226 | 0.200 |
Why?
|
| Heart Failure | 3 | 2020 | 1180 | 0.200 |
Why?
|
| Cell Differentiation | 4 | 2016 | 1034 | 0.200 |
Why?
|
| Cell Line | 4 | 2018 | 1752 | 0.200 |
Why?
|
| Histones | 2 | 2014 | 111 | 0.200 |
Why?
|
| RNA, Messenger | 8 | 2015 | 1664 | 0.200 |
Why?
|
| Triazoles | 1 | 2020 | 43 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 71 | 0.180 |
Why?
|
| Protein Conformation | 3 | 2016 | 362 | 0.180 |
Why?
|
| Aspartic Acid | 3 | 2000 | 65 | 0.180 |
Why?
|
| Schiff Bases | 1 | 1999 | 12 | 0.180 |
Why?
|
| Cysteine | 7 | 1997 | 112 | 0.170 |
Why?
|
| Transcriptome | 1 | 2021 | 164 | 0.170 |
Why?
|
| Mitochondria, Heart | 1 | 2020 | 53 | 0.170 |
Why?
|
| Mutant Proteins | 1 | 1999 | 45 | 0.170 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 137 | 0.170 |
Why?
|
| Pyrazoles | 1 | 2020 | 190 | 0.170 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 1999 | 3 | 0.170 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 133 | 0.170 |
Why?
|
| Enzyme Activation | 3 | 2009 | 791 | 0.160 |
Why?
|
| Amino Acid Sequence | 11 | 1999 | 1083 | 0.160 |
Why?
|
| B7-2 Antigen | 1 | 2018 | 23 | 0.160 |
Why?
|
| Leukocyte Common Antigens | 1 | 2018 | 41 | 0.160 |
Why?
|
| CD11b Antigen | 1 | 2018 | 47 | 0.160 |
Why?
|
| Muscle Proteins | 3 | 2013 | 94 | 0.150 |
Why?
|
| Succinate Dehydrogenase | 1 | 2017 | 13 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 1999 | 183 | 0.150 |
Why?
|
| Photochemistry | 5 | 1999 | 46 | 0.150 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 56 | 0.150 |
Why?
|
| Adenoviridae | 4 | 2006 | 295 | 0.150 |
Why?
|
| Leukocytes | 1 | 2018 | 99 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 277 | 0.150 |
Why?
|
| Ventricular Function | 1 | 2017 | 93 | 0.150 |
Why?
|
| Biomimetics | 1 | 2017 | 17 | 0.150 |
Why?
|
| Cell Survival | 2 | 2017 | 901 | 0.150 |
Why?
|
| Paclitaxel | 3 | 2006 | 140 | 0.140 |
Why?
|
| Monocytes | 1 | 2018 | 210 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1174 | 0.140 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 45 | 0.140 |
Why?
|
| Electric Conductivity | 1 | 2017 | 87 | 0.140 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 258 | 0.140 |
Why?
|
| Structure-Activity Relationship | 3 | 2016 | 420 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 700 | 0.140 |
Why?
|
| Halobacterium salinarum | 5 | 2000 | 15 | 0.130 |
Why?
|
| YY1 Transcription Factor | 1 | 2015 | 6 | 0.130 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 371 | 0.130 |
Why?
|
| Sarcoplasmic Reticulum | 2 | 1993 | 40 | 0.130 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 82 | 0.130 |
Why?
|
| Electric Stimulation | 1 | 2016 | 218 | 0.130 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 157 | 0.130 |
Why?
|
| Ischemic Preconditioning | 1 | 2015 | 31 | 0.130 |
Why?
|
| Mitral Valve Prolapse | 1 | 2015 | 40 | 0.130 |
Why?
|
| Cadherins | 1 | 2015 | 93 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 189 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 163 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2015 | 1692 | 0.120 |
Why?
|
| Recombinant Proteins | 4 | 2005 | 742 | 0.120 |
Why?
|
| Catheterization | 1 | 2015 | 209 | 0.120 |
Why?
|
| Macrophages | 1 | 2018 | 647 | 0.120 |
Why?
|
| Histone Deacetylase 6 | 1 | 2014 | 4 | 0.120 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2014 | 10 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 2 | 2011 | 42 | 0.120 |
Why?
|
| Rats, Inbred BN | 2 | 2014 | 51 | 0.120 |
Why?
|
| DNA | 4 | 2005 | 597 | 0.120 |
Why?
|
| Histone Deacetylase 2 | 1 | 2014 | 7 | 0.120 |
Why?
|
| Electroretinography | 2 | 2014 | 122 | 0.120 |
Why?
|
| Catalase | 1 | 2014 | 85 | 0.110 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 122 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2014 | 233 | 0.110 |
Why?
|
| Stem Cells | 2 | 2017 | 248 | 0.110 |
Why?
|
| Halobacterium | 4 | 1997 | 16 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 94 | 0.110 |
Why?
|
| 5' Untranslated Regions | 2 | 2004 | 16 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 149 | 0.110 |
Why?
|
| Retinal Degeneration | 1 | 2014 | 75 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2014 | 954 | 0.110 |
Why?
|
| Indoles | 1 | 2014 | 146 | 0.110 |
Why?
|
| Tissue Engineering | 2 | 2015 | 212 | 0.110 |
Why?
|
| Muscle Cells | 2 | 2002 | 30 | 0.110 |
Why?
|
| Cell Membrane | 5 | 1996 | 525 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2006 | 95 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 2 | 2005 | 247 | 0.110 |
Why?
|
| Integrins | 3 | 2002 | 115 | 0.110 |
Why?
|
| Phenylephrine | 2 | 2005 | 61 | 0.110 |
Why?
|
| GATA4 Transcription Factor | 1 | 2012 | 33 | 0.100 |
Why?
|
| Adenylyl Cyclases | 1 | 2011 | 94 | 0.100 |
Why?
|
| Biological Transport | 4 | 1999 | 210 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2006 | 88 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 2791 | 0.100 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 102 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 1992 | 202 | 0.100 |
Why?
|
| Cicatrix | 1 | 2011 | 60 | 0.100 |
Why?
|
| Neuroprotective Agents | 2 | 2014 | 317 | 0.100 |
Why?
|
| Molecular Weight | 4 | 1996 | 358 | 0.100 |
Why?
|
| Gene Expression | 4 | 1999 | 770 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2010 | 45 | 0.090 |
Why?
|
| Exons | 2 | 2002 | 122 | 0.090 |
Why?
|
| Collagen | 2 | 2011 | 636 | 0.090 |
Why?
|
| Vanadates | 3 | 1996 | 12 | 0.090 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2010 | 22 | 0.090 |
Why?
|
| Versicans | 1 | 2010 | 44 | 0.090 |
Why?
|
| Darkness | 3 | 2000 | 27 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 71 | 0.090 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2010 | 74 | 0.090 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2009 | 5 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 39 | 0.090 |
Why?
|
| Calcium Channels, L-Type | 1 | 2009 | 34 | 0.080 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2009 | 43 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2010 | 100 | 0.080 |
Why?
|
| Cyclic AMP | 1 | 2009 | 223 | 0.080 |
Why?
|
| Phenotype | 4 | 2017 | 947 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 138 | 0.080 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2009 | 98 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2009 | 235 | 0.080 |
Why?
|
| Adenosine Triphosphate | 3 | 1996 | 314 | 0.080 |
Why?
|
| Protein Binding | 2 | 2009 | 1027 | 0.080 |
Why?
|
| Deuterium Oxide | 2 | 1999 | 6 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 189 | 0.080 |
Why?
|
| Serum Response Factor | 2 | 2012 | 15 | 0.080 |
Why?
|
| Leucine | 2 | 2006 | 41 | 0.080 |
Why?
|
| Time Factors | 4 | 2009 | 4655 | 0.080 |
Why?
|
| DNA Primers | 3 | 2002 | 302 | 0.080 |
Why?
|
| Models, Biological | 3 | 2022 | 981 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2002 | 272 | 0.070 |
Why?
|
| Adaptation, Physiological | 2 | 1999 | 189 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1174 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 626 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2008 | 140 | 0.070 |
Why?
|
| Mesoderm | 1 | 2008 | 231 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 331 | 0.070 |
Why?
|
| Genomic Library | 2 | 1997 | 18 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 199 | 0.070 |
Why?
|
| Cricetinae | 5 | 2008 | 262 | 0.070 |
Why?
|
| Transgenes | 1 | 2006 | 92 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2006 | 52 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 1997 | 357 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 176 | 0.070 |
Why?
|
| Mitosis | 1 | 2006 | 76 | 0.060 |
Why?
|
| Luciferases | 1 | 2005 | 105 | 0.060 |
Why?
|
| Glutamic Acid | 2 | 1999 | 332 | 0.060 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2017 | 45 | 0.060 |
Why?
|
| Fibrosis | 2 | 2020 | 371 | 0.060 |
Why?
|
| Models, Molecular | 3 | 1999 | 546 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2010 | 396 | 0.060 |
Why?
|
| Imidazoles | 1 | 2005 | 175 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2004 | 19 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2006 | 137 | 0.060 |
Why?
|
| Aging | 1 | 2009 | 911 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 181 | 0.060 |
Why?
|
| Genes, Bacterial | 3 | 1996 | 40 | 0.050 |
Why?
|
| Phosphates | 2 | 1993 | 72 | 0.050 |
Why?
|
| Lactose | 6 | 1991 | 7 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2002 | 32 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 282 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 140 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 31 | 0.050 |
Why?
|
| Female | 5 | 2015 | 38074 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 659 | 0.050 |
Why?
|
| Kidney | 2 | 1997 | 945 | 0.050 |
Why?
|
| Autoradiography | 2 | 2008 | 94 | 0.050 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 2 | 2000 | 26 | 0.050 |
Why?
|
| Genotype | 3 | 2008 | 786 | 0.050 |
Why?
|
| Dark Adaptation | 3 | 1997 | 39 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2020 | 147 | 0.050 |
Why?
|
| Cardiotoxicity | 1 | 2020 | 12 | 0.040 |
Why?
|
| Histidine | 1 | 2000 | 17 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2000 | 62 | 0.040 |
Why?
|
| Tyrosine | 2 | 2000 | 196 | 0.040 |
Why?
|
| Transfection | 4 | 2006 | 782 | 0.040 |
Why?
|
| Pigments, Biological | 1 | 1999 | 15 | 0.040 |
Why?
|
| Absorption | 1 | 1999 | 49 | 0.040 |
Why?
|
| Color | 1 | 1999 | 50 | 0.040 |
Why?
|
| Diastole | 1 | 2020 | 161 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 1999 | 169 | 0.040 |
Why?
|
| Extracellular Space | 1 | 1999 | 121 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 1999 | 19 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2000 | 214 | 0.040 |
Why?
|
| Titrimetry | 1 | 1999 | 11 | 0.040 |
Why?
|
| Mathematical Computing | 1 | 1999 | 12 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 1997 | 208 | 0.040 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1999 | 57 | 0.040 |
Why?
|
| Azides | 1 | 1999 | 56 | 0.040 |
Why?
|
| Multigene Family | 1 | 1999 | 93 | 0.040 |
Why?
|
| Electrochemistry | 2 | 1997 | 70 | 0.040 |
Why?
|
| Catalysis | 1 | 1999 | 123 | 0.040 |
Why?
|
| Glutamine | 1 | 1999 | 45 | 0.040 |
Why?
|
| Plasmids | 3 | 1991 | 258 | 0.040 |
Why?
|
| Genes | 2 | 2010 | 86 | 0.040 |
Why?
|
| Serine | 2 | 2010 | 99 | 0.040 |
Why?
|
| Oxygen | 1 | 2020 | 386 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 1997 | 3 | 0.040 |
Why?
|
| Cytokines | 1 | 2022 | 866 | 0.040 |
Why?
|
| Models, Chemical | 1 | 1999 | 155 | 0.040 |
Why?
|
| CHO Cells | 3 | 2006 | 161 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2020 | 586 | 0.040 |
Why?
|
| Binding Sites | 4 | 2006 | 631 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 230 | 0.040 |
Why?
|
| Cell Size | 1 | 2017 | 76 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 1997 | 282 | 0.040 |
Why?
|
| Actins | 3 | 2008 | 249 | 0.030 |
Why?
|
| Cell Count | 1 | 2017 | 248 | 0.030 |
Why?
|
| Zymomonas | 1 | 1996 | 1 | 0.030 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1996 | 14 | 0.030 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1996 | 36 | 0.030 |
Why?
|
| Point Mutation | 1 | 1996 | 97 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 1996 | 71 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2017 | 221 | 0.030 |
Why?
|
| Cadherin Related Proteins | 1 | 2015 | 9 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 231 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2015 | 32 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 376 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1996 | 173 | 0.030 |
Why?
|
| Isomerism | 1 | 1995 | 63 | 0.030 |
Why?
|
| Body Patterning | 1 | 2015 | 44 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2010 | 251 | 0.030 |
Why?
|
| Pedigree | 1 | 2015 | 159 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 1995 | 81 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 90 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 100 | 0.030 |
Why?
|
| Immobilization | 1 | 1994 | 26 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 492 | 0.030 |
Why?
|
| Retinal Neurons | 1 | 2014 | 9 | 0.030 |
Why?
|
| Cytoskeleton | 2 | 2008 | 84 | 0.030 |
Why?
|
| Homeostasis | 1 | 1996 | 291 | 0.030 |
Why?
|
| Zebrafish | 1 | 2015 | 187 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2015 | 166 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2006 | 312 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 111 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 765 | 0.030 |
Why?
|
| Ultracentrifugation | 1 | 1993 | 10 | 0.030 |
Why?
|
| Valproic Acid | 1 | 2014 | 93 | 0.030 |
Why?
|
| Hydroxylamine | 1 | 1993 | 9 | 0.030 |
Why?
|
| Retinaldehyde | 1 | 1994 | 115 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1993 | 29 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 1993 | 34 | 0.030 |
Why?
|
| Hydroxylamines | 1 | 1993 | 20 | 0.030 |
Why?
|
| Alanine | 1 | 1993 | 38 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1996 | 483 | 0.030 |
Why?
|
| Histone Acetyltransferases | 1 | 2013 | 13 | 0.030 |
Why?
|
| Tetracycline | 2 | 2006 | 29 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2013 | 40 | 0.030 |
Why?
|
| Anions | 1 | 1992 | 12 | 0.030 |
Why?
|
| Ribonucleotides | 1 | 1992 | 26 | 0.030 |
Why?
|
| Cell Movement | 1 | 2015 | 630 | 0.030 |
Why?
|
| Cations | 1 | 1992 | 51 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1992 | 234 | 0.030 |
Why?
|
| Muscle Denervation | 1 | 1991 | 1 | 0.030 |
Why?
|
| Muscle Development | 1 | 2011 | 31 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 58 | 0.020 |
Why?
|
| Muscles | 1 | 1991 | 158 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1994 | 396 | 0.020 |
Why?
|
| Luciferases, Firefly | 1 | 2010 | 5 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2008 | 351 | 0.020 |
Why?
|
| Regeneration | 1 | 2011 | 105 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2012 | 237 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2006 | 332 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 40 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 67 | 0.020 |
Why?
|
| Protein Isoforms | 2 | 2002 | 246 | 0.020 |
Why?
|
| ADAMTS9 Protein | 1 | 2010 | 4 | 0.020 |
Why?
|
| Lac Operon | 1 | 2010 | 54 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2010 | 53 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 252 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2010 | 102 | 0.020 |
Why?
|
| Heart Ventricles | 2 | 2010 | 738 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 322 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 337 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 284 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2010 | 85 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1986 | 95 | 0.020 |
Why?
|
| Photolysis | 2 | 2000 | 16 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 515 | 0.020 |
Why?
|
| Aorta | 1 | 2010 | 316 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2000 | 195 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 1987 | 33 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 21403 | 0.020 |
Why?
|
| Endocardium | 1 | 2008 | 101 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2008 | 155 | 0.020 |
Why?
|
| Heart Valve Diseases | 1 | 2008 | 123 | 0.020 |
Why?
|
| Brain | 1 | 1997 | 2176 | 0.020 |
Why?
|
| Proton Pumps | 2 | 1997 | 13 | 0.020 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1985 | 6 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1985 | 49 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 215 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 1986 | 150 | 0.020 |
Why?
|
| Spectrophotometry | 2 | 1997 | 54 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 323 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 384 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 596 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 852 | 0.010 |
Why?
|
| Hypertension | 1 | 1993 | 1535 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 92 | 0.010 |
Why?
|
| Membrane Transport Modulators | 3 | 1991 | 23 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2003 | 49 | 0.010 |
Why?
|
| Hindlimb | 2 | 1994 | 38 | 0.010 |
Why?
|
| Immunoblotting | 2 | 1994 | 254 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 74 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 88 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 173 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2002 | 81 | 0.010 |
Why?
|
| Ethylmaleimide | 3 | 1986 | 9 | 0.010 |
Why?
|
| Vitronectin | 1 | 2000 | 12 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2000 | 27 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2000 | 26 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 2000 | 35 | 0.010 |
Why?
|
| Laminin | 1 | 2000 | 62 | 0.010 |
Why?
|
| Fibronectins | 1 | 2000 | 130 | 0.010 |
Why?
|
| Purple Membrane | 1 | 2000 | 3 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 150 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 147 | 0.010 |
Why?
|
| Proteolipids | 2 | 1991 | 20 | 0.010 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 1999 | 21 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1999 | 223 | 0.010 |
Why?
|
| Age Factors | 1 | 2003 | 1864 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1999 | 261 | 0.010 |
Why?
|
| Peptide Initiation Factors | 1 | 1997 | 11 | 0.010 |
Why?
|
| Blood Volume | 1 | 1997 | 47 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 95 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1997 | 11 | 0.010 |
Why?
|
| Peptides | 1 | 2000 | 455 | 0.010 |
Why?
|
| Guanidine | 1 | 1997 | 7 | 0.010 |
Why?
|
| Guanidines | 1 | 1997 | 32 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 1997 | 67 | 0.010 |
Why?
|
| Proteins | 1 | 2000 | 474 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 1997 | 108 | 0.010 |
Why?
|
| Biological Transport, Active | 2 | 1985 | 49 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1997 | 284 | 0.010 |
Why?
|
| Denervation | 1 | 1994 | 23 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 1994 | 34 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1994 | 66 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 189 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1994 | 80 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1993 | 67 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1993 | 27 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1994 | 371 | 0.010 |
Why?
|
| Liposomes | 1 | 1993 | 107 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 1991 | 17 | 0.010 |
Why?
|
| Naphthoquinones | 1 | 1991 | 14 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1997 | 1451 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 532 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1991 | 200 | 0.010 |
Why?
|
| Freeze Fracturing | 1 | 1987 | 11 | 0.000 |
Why?
|
| Tantalum | 1 | 1987 | 6 | 0.000 |
Why?
|
| Platinum | 1 | 1987 | 17 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1987 | 122 | 0.000 |
Why?
|
| Carbon | 1 | 1987 | 122 | 0.000 |
Why?
|
| Thiogalactosides | 1 | 1986 | 1 | 0.000 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 1986 | 7 | 0.000 |
Why?
|
| Sulfhydryl Reagents | 1 | 1985 | 6 | 0.000 |
Why?
|
| Species Specificity | 1 | 1986 | 303 | 0.000 |
Why?
|
| Nitrophenylgalactosides | 1 | 1985 | 1 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1985 | 25 | 0.000 |
Why?
|